IGF-1 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Chain length | 29 amino acids | Based on the GRF(1-29) fragment |
| Appearance | White to off-white lyophilized powder | Common research supply form |
| Solubility | Soluble in water and aqueous buffers | Powder requires reconstitution before use |
| Typical storage | −20 °C or below | Kept away from light and moisture |
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
1 June – Caltech reports the first successful beaming of solar energy from space down to a receiver on the ground, via the MAPLE instrument on its SSPD-1 spacecraft, launched into orbit in January. 2 June – Physicist Lucas Lombriser proposes a controversial alternative way of interpreting the available scientific data which suggests that the notion of an expanding universe may be more a "mirage" than otherwise. 5 June Scientists report potential evidence that Homo naledi, an extinct species of small-brained archaic human discovered in 2013 in South Africa, and living as long as 500,000 years ago, buried their dead, created art in their caves and used fire. A 'chef' robot developed is trained to watch and learn from cooking videos, and recreate dishes itself. A first global estimate suggests that an equivalent of ~36% of current annual CO2 emissions from fossil fuels is stored by soil mycelium of mycorrhizal fungi yearly. 6 June – A study finds that the first complete disappearance of Arctic sea ice could occur during the 2030s, a decade earlier than previously forecast. 7 June – Scientists report a new mechanism of central nervous system viral diseases including COVID-19 – fusion of brain cells. 8 June US scientists confirm that the next El Niño has begun, likely resulting in higher global temperatures in late 2023 and into 2024. Various statistics show the year is unusual and climate change is already having significant impacts such as an Antarctic sea ice extent anomaly and record-high ocean surface temperatures.
=== Adoption in precolonial scholarship === The earliest attempt to associate the people of the Gold Coast with ancient Ghana had been made by Rev. J. B. Anaman around the turn of the 20th century. Anaman drew on W.D. Cooley's 19th-century interpretation of Arabic geographical sources to make an argument for a historical connection, suggesting an alternative derivation connecting the name to the Wangara people. Lady Flora Shaw later compiled both Arabic and European writings to create detailed narratives of the kingdom. She presented it as a major African power comparable to contemporary Western European states. According to Jack Goody, the theory that the Akan peoples originated from the medieval Empire of Ghana was continuously promoted through the teachings of Rev. W. T. Balmer between 1907 and 1911, who instructed students that the Akan had migrated from the ancient kingdom located near the Upper Niger. Goody states that Balmer's hypothesis lacked linguistic and historical evidence, yet it later became influential among educated elites and nationalist intellectuals. The hypothesis gained more popularity when it was introduced into educational institutions, primarily in Achimota, during the 1920s where it later spread to other schools. The theory was later publicized by J. B. Danquah's academic writings; he used Arabic and French translations to claim that the Akan migrated from the Upper Niger region. Danquah proposed that the term Ghana was a corruption of Akane or Akana and associated it with the ancient region of Akkad. Eva L. R.
== Journal of Wound Management == The Journal of Wound Management is the official journal of the European Wound Management Association (EWMA). Issues are published in January, May and October. EWMA Journal is CINAHL indexed and provides peer-reviewed original scientific articles, reviews, clinical information, and information about development in wound healing and management across Europe. The Journal also functions as a communication tool between EWMA, its members and the EWMA cooperating Organisations. The Journal is freely available online under terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) which means that anybody can copy, redistribute in any medium or format, adapt, remix, transform and make indicated changes with appropriate credit. It is prohibited to use the articles for commercial purposes. It is distributed to EWMA members and to members of national wound healing organisations in Europe, as well as to a wider audience via the internet. As a result, each issue of the EWMA Journal is distributed to 12-13,000 nurses, doctors and other health care professionals who have a special interest in wound care.
Sources: en.wikipedia.org
== 1961–64 == South Africa's isolation increased in 1960–61 when it declared a republic and left the Commonwealth. SAOCGA was renamed SAONGA (the South African Olympic and National Games Association) as it was no longer eligible for the Commonwealth Games; it was later more usually called SANOC (South Africa National Olympic Committee). In 1962, Jan de Klerk announced a ban on South Africans appearing in mixed-race competition inside or outside the country. In 1963, Dennis Brutus founded the South African Non-Racial Olympic Committee (SANROC) which lobbied the IOC to expel SAONGA. Brutus was subjected to travel restrictions and forbidden from attending meetings, so he fled to London. The IOC moved its 1963 conference from Nairobi to Baden-Baden after the Kenyan government refused to grant a visa to the South African delegate. To bypass its own ban on mixed-race competition, SANOC was prepared to stage its Olympic trials abroad, but the events would still be segregated. The IOC voted to revoke SANOC's invitation to the 1964 Summer Olympics unless it declared its opposition to the government's policy. SANOC did not do so and was excluded from the Games, although it remained affiliated to the IOC.
terminator A DNA sequence or its RNA complement which signals the termination of transcription by triggering processes that ultimately arrest the activity of RNA polymerase and/or cause the release of the nascent RNA transcript from the transcriptional complex. Terminator sequences are usually found near the 3'-ends of the coding sequences of genes or operons. They generally function after being themselves transcribed into the nascent strand, whereupon the part of the strand containing the sequence either directly interacts with the transcriptional complex or a cofactor or forms a secondary structure such as a hairpin loop which signals the recruitment of enzymes that promote its disassembly.
Seeded 13th, he earned his first victory over Alexander Bublik by beating him in the first round in three sets. In the second round, he defeated world No. 29, Roberto Bautista Agut, in the second round. In the third round, he lost to third seed, Daniil Medvedev, despite serving for the match twice and having two match points in the third-set tie-break. This defeat was his seventh out of the last eight matches played with Medvedev. Seeded third at the BMW Open in Munich, he was defeated in the second round by Christopher O'Connell. Seeded 13th at the Madrid Open, he recorded his 350th career win by defeating Roberto Carballés Baena in the second round, becoming the only player under 30 to reach this milestone. In the third round, he overpowered qualifier, Hugo Grenier, in 55 minutes. In the fourth round, he lost to top seed, world No. 2, defending champion, and eventual champion, Carlos Alcaraz, in a rematch of the previous year's final. Failing to defend his finalist points from last year, his ranking fell from 16 to 22. Seeded 19th at the Italian Open, he made it to the fourth round where he lost to third seed and eventual champion, Daniil Medvedev. Having made the semifinals last year, his ranking again fell, this time from 22 to 27. Seeded third at the Geneva Open, he reached the semifinal where he lost to Nicolás Jarry, who would end up winning the tournament. Seeded 22nd at the French Open, he defeated Lloyd Harris, Alex Molčan, 12th seed Frances Tiafoe, and 28th seed Grigor Dimitrov in his first four rounds. In the quarterfinals, he faced Tomás Martín Etcheverry.
Merle Sheffield, The Chain and Boom, Hudson River Valley, official website West Point Fortifications The Great Chain Chaining of the Hudson in 1778 Archived February 16, 2008, at the Wayback Machine The Great Chain Chaining The Hudson George Washington's letter about the strategic importance of the Hudson Contract for the forging of The Great Chain New York Times Article about The Chain February 17, 1895 Chain Salvaging Blurb "Revolutionary West Point: 'The Key to the Continent'",
Sources: en.wikipedia.org
=== Light novel === Written by Kana Akatsuki and illustrated by Suoh, Agents of the Four Seasons began publication under ASCII Media Works' Dengeki Bunko light novel imprint on April 9, 2021. Eight volumes have been released as of December 2024. During their panel at MCM Comic Con London 2023, Yen Press announced that they licensed the series for English publication.
==== Electronic structure ==== Plutonium is an element in which the 5f electrons are the transition border between delocalized and localized; it is therefore considered one of the most complex elements. The anomalous behavior of plutonium is caused by its electronic structure. The energy difference between the 6d and 5f subshells is very low. The size of the 5f shell is just enough to allow the electrons to form bonds within the lattice, on the very boundary between localized and bonding behavior. The proximity of energy levels leads to multiple low-energy electron configurations with near equal energy levels. This leads to competing 5fn7s2 and 5fn−16d17s2 configurations, which causes the complexity of its chemical behavior. The highly directional nature of 5f orbitals is responsible for directional covalent bonds in molecules and complexes of plutonium.
=== Gender dysphoria === Many international guidelines and institutions require persistent, well-documented gender dysphoria as a pre-requisite to starting gender-affirmation therapy. Gender dysphoria refers to the psychological discomfort or distress that an individual can experience if their sex assigned at birth is incongruent with that person's gender identity. Signs of gender dysphoria can include comorbid mental health stressors such as depression, anxiety, low self-esteem, and social isolation. Not all gender nonconforming individuals experience gender dysphoria, and measuring a person's gender dysphoria is critical when considering medical intervention for gender nonconformity.
The following season, VfB Leipzig found themselves unable to cover the expense of travelling to participate in their scheduled first-round playoff match and so were eliminated from that year's competition. However, they did go on to raise the Viktoria again in 1906 and 1913 and also played in the 1911 and 1914 finals. In the period leading up to World War II, VfB Leipzig was unable to repeat its early success. Gyula Kertész coached the side from 1932 to 1933. After the reorganization of German football leagues under the Third Reich in 1933, the club found itself in Gauliga Sachsen, one of the 16 upper-tier divisions. While they earned strong results within their own division, they were unable to advance in the playoff rounds. In 1937, they won the Tschammerpokal, known today as the DFB-Pokal, in a match against Schalke 04, the dominant side of the era.
== Further reading == American Geological Institute, 2003, Dictionary of Mining, Mineral, and Related Terms, second ed., Springer, New York, ISBN 978-3-540-01271-9. David Rickard, Pyrite: A Natural History of Fool's Gold, Oxford / New York, 2015, ISBN 978-0-19-020367-2.
Sources: en.wikipedia.org
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.
DAC stands for drug affinity complex, a chemical group that binds the peptide to serum albumin. The binding slows clearance and lengthens the time the molecule stays in plasma compared with the unmodified analog.
Because two distinct molecules are discussed under one informal label. The albumin-binding version clears over several days, while the form without that group clears within roughly half an hour. Mixing results from both creates inconsistent figures.
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.